Filtered By:
Specialty: Cancer & Oncology
Condition: Heart Attack

This page shows you your search results in order of date. This is page number 9.

Order by Relevance | Date

Total 138 results found since Jan 2013.

Acute ischaemic stroke and myocardial infarction after chemotherapy with vinorelbine for non-small cell lung cancer: a case report.
We report about a 70-year-old male with metastatic non-small cell lung cancer who received vinorelbine as an outpatient. The patient presents with a cardiovascular risk profile. He was admitted to the hospital 3 days later with acute left-sided hemiplegia and hemianopia. Brain computed tomography (CT) demonstrated acute right hemispheric ischaemic stroke. Nine days after admission, the patient additionally suffered ST elevation myocardial infarction. A coronary angiogram demonstrated high grade stenosis of the right coronary artery treated with two bare-metal stents. Caution should be noted in patients who present with a c...
Source: Journal of Chemotherapy - November 18, 2015 Category: Cancer & Oncology Tags: J Chemother Source Type: research

Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment.
CONCLUSIONS: Variations in patients' willingness to tolerate different treatment-related adverse events underscore the need for improved communications between physicians and patients about the risks and benefits of their medical treatment, which helps make a more personalized decision for metastatic CRC treatment. PMID: 26577827 [PubMed - as supplied by publisher]
Source: Clinical Colorectal Cancer - November 18, 2015 Category: Cancer & Oncology Authors: Fu AZ, Graves KD, Jensen RE, Marshall JL, Formoso M, Potosky AL Tags: J Cancer Res Clin Oncol Source Type: research

Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment
Conclusions Variations in patients’ willingness to tolerate different treatment-related adverse events underscore the need for improved communications between physicians and patients about the risks and benefits of their medical treatment, which helps make a more personalized decision for metastatic CRC treatment.
Source: Journal of Cancer Research and Clinical Oncology - November 18, 2015 Category: Cancer & Oncology Source Type: research

It’s Never Too Late to Quit Smoking
By Stacy SimonAbout half of all Americans who smoke and don’t quit will die because of smoking. That’s one of the reasons it’s so important to quit, and the sooner the better. But quitting is rewarding no matter how old you are or whether you have health problems. Studies show that even after age 80, people can live healthier if they give up cigarettes.And the benefits are almost immediate. Ex-smokers have fewer illnesses such as colds and the flu, lower rates of bronchitis and pneumonia, and feel healthier than people who still smoke. Just 20 minutes after quitting, your heart and blood pressure drop. In...
Source: American Cancer Society :: News and Features - November 16, 2015 Category: Cancer & Oncology Tags: Smoking/Tobacco Source Type: news

Hemodynamic Stability During Pheochromocytoma Resection: Lessons Learned Over the Last Two Decades
Conclusions Postoperative outcomes following pheo resection have improved over the last two decades. Preoperative α-blockade plays a significant role in improving intraoperative hemodynamics and post-op outcomes. Increased doses of phenoxybenzamine and utilization of laparoscopic approaches have likely contributed to improved outcomes in the last decade. Intraoperative magnesium use may provide protection against hemodynamic instability and warrants further study.
Source: Annals of Surgical Oncology - November 14, 2015 Category: Cancer & Oncology Source Type: research

Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma
CONCLUSIONSSunitinib and sorafenib might be associated with an increased risk of cardiovascular events and particularly stroke. Cancer 2015. © 2015 American Cancer Society.
Source: Cancer - October 6, 2015 Category: Cancer & Oncology Authors: Sekwon Jang, Chaoyi Zheng, Huei‐Ting Tsai, Alex Z. Fu, Ana Barac, Michael B. Atkins, Andrew N. Freedman, Lori Minasian, Arnold L. Potosky Tags: Original Article Source Type: research

Abstract 882: Obesity, comorbidity and endometrial cancer survival: the multiethnic cohort
We examined the association of pre-diagnostic BMI and obesity-related comorbidities with overall survival in African-American, Japanese, Native Hawaiian, Latino and white women in the Multiethnic Cohort.Methods: Women with complete risk factor data who developed endometrial cancer during follow up were included in the analysis (N = 998). BMI and obesity-related comorbidities (diabetes, hypertension, heart attack and stroke) were self-reported at cohort entry and at subsequent follow-ups. Cox's models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) with time-varying exposures in relation to all...
Source: Cancer Research - August 2, 2015 Category: Cancer & Oncology Authors: Setiawan, V. W., Maskarinec, G., Lin, Y. G., Yang, D., Wilkens, L. R., Henderson, B. E., Le Marchand, L. Tags: Epidemiology Source Type: research

Survey shows half of older adults in US now taking aspirin
(Oregon State University) A national survey suggests that slightly more than half of the older adults in the United States are now taking a daily dose of aspirin, even though its use is not recommended by the Food and Drug Administration for most people who have not yet had a heart attack or stroke. The findings suggest that tens of millions of Americans have reviewed the issues involved, often discussed it with their doctors, say they know what they are doing -- and decided to use aspirin.
Source: EurekAlert! - Cancer - April 16, 2015 Category: Cancer & Oncology Source Type: news

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
Background: The incidence of non-alcoholic steatohepatitis (NASH) is increasing worldwide and a poorly defined subset of patients develops end-stage liver disease and hepatocellular carcinoma (HCC). Differences in the biological behaviour, tumour characteristics, associated risk factors, treatment outcomes and overall survival of patients with NASH-HCC remain poorly defined. The aim of this study was to determine and analyze these differences in a large clinical cohort to guide treatment decisions. Methods: 1119 patients with HCC treated in an 11 year period at the University Medical Centre of the Johannes Gutenberg Unive...
Source: BMC Cancer - April 1, 2015 Category: Cancer & Oncology Authors: Arndt WeinmannYvonne AltSandra KochCarina NellesChristoph DüberHauke LangGerd OttoTim ZimmermannJens MarquardtPeter GalleMarcus WörnsJörn Schattenberg Source Type: research

Researchers hope patent can pave way to future treatments of heart, lung disease
(Kansas State University) Researchers have received a patent for a peptide that has been shown to prevent or reduce damage to intestinal tissue. Their ongoing work may have far-reaching implications, including new ways to treat tissue damaged during a heart attack or stroke, and even a possible cure for cancer.
Source: EurekAlert! - Cancer - December 18, 2014 Category: Cancer & Oncology Source Type: news

Estimates of benefits and harms of prophylactic use of aspirin in the general population
Conclusions Prophylactic aspirin use for a minimum of 5 years at doses between 75 and 325 mg/day appears to have favourable benefit–harm profile; longer use is likely to have greater benefits. Further research is needed to determine the optimum dose and duration of use, to identify individuals at increased risk of bleeding, and to test effectiveness of Helicobacter pylori screening–eradication before starting aspirin prophylaxis.
Source: Annals of Oncology - December 17, 2014 Category: Cancer & Oncology Authors: Cuzick, J., Thorat, M. A., Bosetti, C., Brown, P. H., Burn, J., Cook, N. R., Ford, L. G., Jacobs, E. J., Jankowski, J. A., La Vecchia, C., Law, M., Meyskens, F., Rothwell, P. M., Senn, H. J., Umar, A. Tags: reviews Source Type: research

Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events.
CONCLUSIONS: The economic burden of adverse events is relevant to programs and policies from clinic to government, and that burden merits consideration in the risks and benefits of adt. PMID: 24940106 [PubMed]
Source: Current Oncology - November 19, 2014 Category: Cancer & Oncology Tags: Curr Oncol Source Type: research

Diabetes Mellitus and Increased Postoperative Risk of Acute Renal Failure After Hepatectomy for Hepatocellular Carcinoma: A Nationwide Population-Based Study
Conclusions DM is associated with a significantly high risk of septicemia and acute renal failure, but not with other major complications or mortality, after hepatectomy for HCC.
Source: Annals of Surgical Oncology - October 8, 2014 Category: Cancer & Oncology Source Type: research

Scientists wield plant viruses against deadly human disease
(Case Western Reserve University) Case Western Reserve University researchers have won grants to customize a plant virus into a vaccine for an aggressive form of breast cancer, and to turn another plant virus into a transporter that delivers clot-busting drugs to a blood clot before it causes a heart attack or stroke.
Source: EurekAlert! - Cancer - October 1, 2014 Category: Cancer & Oncology Source Type: news

432p * patterns and efficacy of bevacizumab use across treatment lines in glioblastoma
Conclusions: Our results show bevacizumab treatment may be more efficient after a recurrence than when used in the beginning of treatment and are in line with reported registration trials data.Disclosure: All authors have declared no conflicts of interest.
Source: Annals of Oncology - September 24, 2014 Category: Cancer & Oncology Authors: Azam, M. B., Rho, Y. S., Mamo, A., Sahebjam, S., Muanza, T., Guiot, M., Al-Shami, J., Sharma, R., Kavan, P. Tags: CNS tumours Source Type: research